Linike Medical Group Ltd.
LNMG
$0.0061
$0.000.00%
OTC PK
| 07/31/2014 | 04/30/2014 | 01/31/2014 | 10/31/2013 | 07/31/2013 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.20K | 19.80K | 38.20K | 24.50K | 60.10K |
| Depreciation & Amortization | -- | -- | -- | 210.20K | 100.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.20K | 19.80K | 38.20K | 234.70K | 60.20K |
| Operating Income | -11.20K | -19.80K | -38.20K | -234.70K | -60.20K |
| Income Before Tax | -10.40K | -22.80K | -38.20K | -235.50K | -61.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.40K | -22.80K | -38.20K | -235.50K | -61.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.40K | -22.80K | -38.20K | -235.50K | -61.80K |
| EBIT | -11.20K | -19.80K | -38.20K | -234.70K | -60.20K |
| EBITDA | -11.00K | -19.60K | -38.00K | -234.60K | -60.10K |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.09 | -0.04 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.06 | -0.02 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.09 | -0.04 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.06 | -0.02 |
| Average Basic Shares Outstanding | 3.47M | 3.47M | 3.47M | 2.63M | 1.57M |
| Average Diluted Shares Outstanding | 3.47M | 3.47M | 3.47M | 2.63M | 1.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |